PRMT5 and cancer: Although the proteomic data was collated from bulk cells from 12 different cancer cell lines originating from the breast, ovary, liver and pancreas, and we have not examined protein levels of DDR genes that undergo differential splicing after GSK591 in BCSCs, this does suggest that the mechanism by which PRMT5 regulates protein expression and function is divergent dependent on cancer origin and cell type.